Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
5.08
-0.41 (-7.47%)
At close: Apr 1, 2025, 4:00 PM
5.02
-0.06 (-1.18%)
After-hours: Apr 1, 2025, 7:57 PM EDT

Xeris Biopharma Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Net Income
-54.84-62.26-94.66-122.73-91.14
Upgrade
Depreciation & Amortization
12.6313.1612.671.881.47
Upgrade
Other Amortization
3.012.211.560.960.98
Upgrade
Loss (Gain) From Sale of Assets
0.090.320.24--
Upgrade
Loss (Gain) From Sale of Investments
-0.75-1.260.180.410.08
Upgrade
Stock-Based Compensation
18.3610.7212.1611.388.27
Upgrade
Other Operating Activities
-6.66-3.610.110.72.58
Upgrade
Change in Accounts Receivable
-1.22-8.37-13.37-6.24-2.18
Upgrade
Change in Inventory
-8.78-14.8-7.47-7.42-5.14
Upgrade
Change in Accounts Payable
-9.616.96-4.325.53-2.49
Upgrade
Change in Other Net Operating Assets
10.799.92-9.9919.987.01
Upgrade
Operating Cash Flow
-36.98-47.02-102.89-95.54-80.56
Upgrade
Capital Expenditures
-0.87-2.26-0.52-1.09-0.38
Upgrade
Cash Acquisitions
---38.47-
Upgrade
Investment in Securities
5.75-3.7434.9960.58-27.03
Upgrade
Investing Cash Flow
4.88-634.4697.96-27.41
Upgrade
Long-Term Debt Issued
50-146.21-94.84
Upgrade
Long-Term Debt Repaid
---43.5--25.09
Upgrade
Net Debt Issued (Repaid)
50-102.72-69.75
Upgrade
Issuance of Common Stock
1.730.5830.8427.8466.7
Upgrade
Repurchase of Common Stock
-3.73-1.01-0.47-0.53-0.06
Upgrade
Other Financing Activities
-11.83-1.19-5.61-0.05-10.32
Upgrade
Financing Cash Flow
36.17-1.61127.4727.25126.06
Upgrade
Foreign Exchange Rate Adjustments
----0-0.02
Upgrade
Net Cash Flow
4.07-54.6459.0429.6718.08
Upgrade
Free Cash Flow
-37.85-49.29-103.42-96.62-80.94
Upgrade
Free Cash Flow Margin
-18.64%-30.07%-93.80%-194.84%-396.06%
Upgrade
Free Cash Flow Per Share
-0.26-0.36-0.76-1.22-1.90
Upgrade
Cash Interest Paid
26.9527.6910.867.294.56
Upgrade
Levered Free Cash Flow
-27.81-19.62-65.85-28.19-52.91
Upgrade
Unlevered Free Cash Flow
-11.76-5.2-58.6-24.67-47.22
Upgrade
Change in Net Working Capital
24.67-0.731.69-29.095.62
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q